Preferred Label : Autologous BCMA/TACI-targeted CAR T Cells AUTO2;

NCIt synonyms : Autologous CAR T Product AUTO2; Autologous APRIL CAR T Cells; APRIL CAR T Cells Targeting BCMA and TACI; APRIL CAR T Cells (AUTO2) Targeting BCMA and TACI;

NCIt definition : A preparation of autologous T-lymphocytes that are genetically engineered to contain a dual-targeted chimeric antigen receptor (CAR), which includes the natural protein a proliferation-inducing ligand (APRIL; TNFSF13), that targets the tumor-associated antigens (TAAs) B-cell maturation antigen (BCMA; TNFRSF17) and transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI; TNFRSF13B), with potential immunomodulating and antineoplastic activities. Upon administration, the autologous BCMA/TACI-targeted CAR T-cells AUTO2 bind to BCMA and TACI expressed on tumor cells and induce selective cytotoxicity in those cells. In addition, AUTO2 carries the universal RQR8 safety off switch, which allows selective removal of the T-cells through both complement-dependent cytotoxicity (CDC) and antibody-dependent cellular cytotoxicity (ADCC) following administration of rituximab if unacceptable side-effects occur.;

Molecule name : AUTO 2; AUTO2; SUB-96123;

NCI Metathesaurus CUI : CL552285;

Details


Keyword's position in hierarchy(ies) : arborescence

Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3518372/fr/derivo-2
2024
France
health technology assessment
Control
Autologous BCMA/TACI-targeted CAR T Cells AUTO2
Disease Controlled
True Control Status
Check
Control Group
Intracranial Route of Administration
Study Control
Stent
cranial cavity, nos
Scientific Control
Stent Device

---
Nous contacter.
10/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.